Canopy Life Sciences

Last week, we were thrilled to welcome Ana Rasack, MBA,?Associate Director of Global Promotional Review at Stemline Therapeutics, to our headquarters to meet the Canopy team she works with daily. Ana met with members of our MLR Coordination team that support her work every day! It was a great chance to dive deeper into our shared goals, discuss future opportunities, and strengthen our partnership. A big thank you to Ana for the visit and for the trust she places in us. We are excited to continue our successful collaboration! #Regulatory #MedicalAffairs #MLR #Pharmaceuticals #Biotech

?? Did you know? 44% of pharma companies have top medical directors reviewing promotional content - often without formal training. It's time to revolutionize your MLR process! Join us tomorrow for Impatient Health's webinar "The Real Cost of MLR”. Discover how to overcome the potential bottlenecks and challenges of in-house review and how to create more efficient processes. ?? Key Takeaways: ??? ?Quantify MLR's impact on resources ??? ?How to free up medical directors' time for strategic work ??? ?Handling increasing digital content efficiently ??? ?Leveraging dedicated MLR roles and outsourcing partners Impatient Health’s expert panel, featuring Jimmie Overton, Pharm D, Canopy's Medical Affairs expert focused in MLR, will offer insights into: ? Effective ways to structure and amplify Medical’s role within MLR ? Solutions that enable your team to focus on core strategic objectives ? Scalable approaches to enhance the efficiency and impact of the medical review process Don't let inefficient MLR hold you back. Transform your approach and boost your Medical Affairs efficiency! ?? Thursday October 31st, 2024 3:00pm London / 4:00pm Paris / 11:00am New York / 8:00am San Francisco ??1 hour ??? Zoom Save your seat! Register here:?https://bit.ly/3UkvnHM #MedicalAffairs #MLR #Pharmaceuticals #Biotech #ImpatientHealth

?? Is inefficient MLR draining your resources and compromising your objectives? Join Impatient Health’s webinar, "The Real Cost of MLR,” delving into strategies to improve efficiency and maximize the value of MLR processes. Jimmie Overton, one of Canopy’s Medical Affairs experts, will be part of Impatient Health’s panel of industry experts discussing: ? New data revealing MLR’s true impact on organizational function ? Challenges of scaling to manage increasing content volume and complexity ? Strategies to structure, optimize, and elevate Medical’s contribution to the MLR team You’ll gain insights into: ? Effective ways to structure and amplify Medical’s role within MLR ? Solutions that enable your team to focus on core strategic objectives ? Scalable approaches to enhance the efficiency and impact of the medical review process Don’t miss this opportunity to uncover hidden truths about MLR and take steps toward a more impactful approach. ?? Thursday October 31st, 2024 3:00pm London / 4:00pm Paris / 11:00am New York/ 8:00am San Francisco ??1 hour ??? Zoom Register now:?https://bit.ly/3UkvnHM #MedicalAffairs #MLR #Pharmaceuticals #Biotech #ImpatientHealth

We are excited to share that Susanne E Clark has been appointed as the new Chief Executive Officer (CEO) of Canopy Life Sciences, stepping into this role to lead Canopy through its next chapter of expansion and innovation. After serving as CEO since 2018, Joe Walsh will transition to the role of Executive Chair, continuing to offer his invaluable strategic guidance. This leadership transition will further strengthen our commitment to both our teams and our clients, driving forward new opportunities and delivering even greater value. Congratulations to Susanne and Joe as they embark on this exciting journey together. We are confident in the bright future ahead under their leadership. Read the full announcement here: https://lnkd.in/eVYEABQJ #Pharmaceutical #biotech #Leadership #regulatoryaffairs #medicalaffairs

We are excited to share that Susanne E Clark has been appointed as the new Chief Executive Officer (CEO) of Canopy Life Sciences, stepping into this role to lead Canopy through its next chapter of expansion and innovation. After serving as CEO since 2018, Joe Walsh will transition to the role of Executive Chair, continuing to offer his invaluable strategic guidance. This leadership transition will further strengthen our commitment to both our teams and our clients, driving forward new opportunities and delivering even greater value. Congratulations to Susanne and Joe as they embark on this exciting journey together. We are confident in the bright future ahead under their leadership. Read the full announcement here: https://lnkd.in/eVYEABQJ #Pharmaceutical #biotech #Leadership #regulatoryaffairs #medicalaffairs

Looking forward to the Opening Ceremony of the 3rd Annual Medical Affairs Innovation Olympics starting later today. Canopy Life Sciences is proud to be a silver sponsor for this event recognizing the profound impact of Medical Affairs upon life sciences and healthcare. #medicalaffairs #MAIO2024 #pharmaceutical #biotech

Join us for Day 2 of the #TOPRA Symposium 2024! Meet Susanne E Clark, Jasbir Chohan and Christine Grew PhD MBA at Stand 36 to discover Canopy's full service portfolio and how we can help support your regulatory activities including: ? Regulatory Strategy ? Regulatory Writing ? CTR & CTIS Support ? EU Clinical Trial Regulation support ? eCTD Applications & Submissions ? Project & Life-Cycle Management ? MS Word & PDF publishing In addition, we have a full-range service portfolio that includes MLR, Content Innovation, Medical Affairs, Global Recruiting, Veeva, and more. View all of our services and solutions at hellocanopy.com???????????????????????????????????????????????????????????????????????????????????? Here to get your science there.

?? Exciting news! Canopy Life Sciences is a finalist in the Support category of the #TOPRA Awards for Regulatory Excellence 2024! ?? Huge kudos to our incredible eCTD publishing team! This recognition underscores our commitment and dedication to delivering exceptional regulatory support for the life sciences sector. ?? Congratulations to all fellow nominees! We're proud to stand with you, showcasing the vital role of support organizations in drug development and lifecycle management. Join us in celebrating on November 28th! #RegAwards24 #regulatoryaffairs #Pharmaceutical #Lifesciences

??? September 30 – October 2, Rotterdam, Netherlands We are excited to be exhibiting at the upcoming #TOPRA Symposium. Meet Susanne E Clark Clark, President, Jasbir Chohan, Head of Regulatory Operations and Christine Grew PhD MBA Grew, Director?at Stand #36 to discover how Canopy can support your regulatory activities. Canopy partners with over 250 clients globally, from emerging biotech to established pharma. Our robust service offering includes Regulatory Operations and Regulatory Affairs plus MLR, Content Innovation, Medical Affairs, Global Recruiting, Veeva, and more. Visit hellocanopy.com to discover more. Here to get your science there. #Pharmaceutical #Lifesciences #regulatoryaffairs #regulatorycompliance #TOPRASym24

Claim statements and properly organized references are crucial for accelerating the MLR review process. However over 75% of life sciences brands using Veeva PromoMats/MedComms have not yet implemented these libraries. And those who have often struggle with monitoring and maintenance. ? Canopy can help simplify this entire process. Utilizing our proprietary technology, our advisors will establish an initial Claims/Medical Statement Library within days, not months. Once the library is set up, the review process may be accelerated up to 30%, compliance is strengthened, and consistent messaging is ensured. Best of all, we also provide the tools and services to help you monitor and maintain the library effortlessly. To learn more, contact us Joanna Bova, PMP (tag LI profile) or?visit www.hellocanopy.com. Canopy’s MLR Offerings include: Coordination, Editorial, Librarian, Marketing Operations, Regulatory Review, Medical Review, Advisory, Training, and full support of Veeva PromoMats and MedComms. Canopy supports over 250 clients and has aided the approval and distribution of over 1.25M pieces of content. Here to get your science there. #RegulatoryReview #DrugDevelopment #Veeva #Pharmaceutical #MedComms?